What is sarcoma?
Sarcomas arise from tissues that support, connect, or structure the body. They are grouped broadly into bone sarcomas and soft tissue sarcomas, but each group contains numerous distinct diseases. Osteosarcoma, chondrosarcoma, Ewing sarcoma, liposarcoma, leiomyosarcoma, angiosarcoma, synovial sarcoma, and gastrointestinal stromal tumor are examples. Some occur mainly in children or young adults, while others are more common later in life. Most sarcomas arise without a known cause. Risk can be increased by certain inherited cancer syndromes, prior radiation, chronic lymphedema, or uncommon chemical exposures, depending on subtype. Because an unplanned biopsy or excision can complicate definitive surgery, suspicious masses are best evaluated with imaging and biopsy planned by a sarcoma-experienced multidisciplinary team. Specialist pathology is also important because rare subtypes may resemble one another. Care depends on whether the tumor begins in bone or soft tissue, exact histology, location, size, grade, stage, resectability, molecular biomarkers, age, and general health.
Signs and symptoms
A soft tissue sarcoma may appear as a painless lump that enlarges over time. Pain, numbness, or weakness can develop when a mass presses on muscles, nerves, or organs. Retroperitoneal or abdominal tumors may grow large before causing fullness, pain, vomiting, constipation, bleeding, or weight loss. Bone sarcomas can cause persistent localized pain, swelling, reduced joint movement, a limp, or a fracture through weakened bone. Chest or lung involvement may cause cough or shortness of breath. Symptoms vary greatly with location and subtype. Most lumps and musculoskeletal pain are caused by injuries, benign tumors, cysts, arthritis, or other noncancer conditions. A mass that is growing, deep, firm, recurrent after removal, or larger than expected deserves assessment. Persistent night pain, unexplained swelling, or a fracture with minimal injury also warrants evaluation rather than self-diagnosis.
Diagnosis and staging
Evaluation begins with examination and imaging chosen for the site. MRI usually defines a limb or pelvic soft-tissue or bone mass; CT is useful for chest, abdominal, retroperitoneal, and bone detail. Chest CT commonly assesses lung spread, and PET, bone scan, or other imaging is selected by subtype. Biopsy should be planned with the surgeon or team that would perform definitive resection so the biopsy path can be removed safely. Core-needle biopsy is common; adequate tissue permits histology, immunohistochemistry, cytogenetics, and molecular testing for subtype-defining fusions or mutations. Pathology review by a sarcoma specialist can change classification. Staging considers tumor size and site, depth for soft-tissue tumors, grade, lymph nodes in selected subtypes, and distant spread, especially to lungs. Some sarcomas use subtype-specific systems such as localized versus metastatic Ewing sarcoma. Care depends on exact type, grade, stage, biomarkers, resectability, age, and overall health.
Established treatment paths
Surgery with an adequate margin is central for many localized sarcomas, while preserving function whenever safely possible. Radiation before or after surgery can improve local control for selected soft-tissue and bone tumors; definitive radiation may be used when surgery is not feasible. Systemic therapy varies sharply by subtype. Osteosarcoma and Ewing sarcoma generally use multi-drug chemotherapy combined with local surgery and/or radiation. Many adult soft-tissue sarcomas are treated primarily with surgery, with chemotherapy considered according to histology, risk, resectability, and spread. Gastrointestinal stromal tumors and some other subtypes can respond to mutation-matched targeted medicines. Immunotherapy has established or emerging roles only in selected histologies or biomarker-defined situations. Metastatic or recurrent disease may be managed with systemic therapy, surgery or focused radiation to limited metastases, symptom-directed treatment, or clinical trials. Amputation is sometimes necessary but limb-sparing approaches are often possible. Care depends on site, subtype, grade, stage, molecular biomarkers, prior therapy, age, organ function, and patient goals. Treatment planning should integrate pathology, radiology, surgery, radiation oncology, and medical or pediatric oncology expertise.
Supportive care
Supportive care focuses on pain control, mobility, wound care, rehabilitation, and preserving function. Physical and occupational therapy, prosthetic or orthotic services, and fall or fracture precautions may be important after bone or limb treatment. Teams manage nausea, fatigue, blood-count changes, nerve symptoms, swelling or lymphedema, and nutritional or emotional needs. Fertility preservation should be discussed before chemotherapy or pelvic radiation when feasible. Palliative care can help with symptoms and decision support at any stage, including alongside surgery or systemic therapy. Children, adolescents, and young adults may need school and developmental support. Follow-up is tailored to subtype and often includes chest and local imaging. Medicines and supplements should be reviewed for interactions and perioperative risks.
Profiles documenting sarcoma care
These profiles mention a matching cancer specialty in their published materials. Browse their locations, reported services, and practical details.
No clinic profile is connected to this guide yet. The wider directory may still offer useful places to explore.
Sources
Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.
- NCI: Soft Tissue Sarcoma—Patient Version ↗Checked 2026-09-29
- NCI: Primary Bone Cancer ↗Checked 2026-09-29
How Cancer Clinic Finder compiles information · Suggest a factual correction
